medline.ch Onkologie

	Analysis of efficacy and safety of transarterial embolization sequential microwave ablation for hepatic hemangioma. Int J Hyperthermia An Y, Lu N, Ma L, Gao W, He N, Yang X, Yuan C. PMID: 42439025 [PubMed - indexed for MEDLINE]
	Mechanistic Links Between Obesity and Breast Cancer Progression: Cellular Crosstalk, Metabolic Reprogramming and Microenvironmental Drivers. Cell Biochem Funct Basson C, Pepper MS, Joubert AM, Ambele MA. PMID: 42439024 [PubMed - indexed for MEDLINE]
	Robotic intracorporeal modified Bordeaux versus Padua ileal bladder: head-to-head surgical technique, perioperative and functional outcomes. Minerva Urol Nephrol Mastroianni R, Tuderti G, Anceschi U, Bove AM, Brassetti A, D'Annunzio S, Ferriero M, Flammia RS, Misuraca L, Proietti F, Licari L, Bologna E, Chiacchio G, Guaglianone S, Leonardo C, Simone G. PMID: 42438988 [PubMed - indexed for MEDLINE]
	Assessing the concordance between ChatGPT-4 and EAU guidelines indications in bladder cancer management: a real-world study. Minerva Urol Nephrol Lo Re M, Cadenar A, Pezzoli M, Mancon S, Fuligni E, Lambertini L, Carlino A, Catanzaro R, DI Dio M, Minervini A, Cocci A. PMID: 42438987 [PubMed - indexed for MEDLINE]
	Preliminary feasibility of SHURUI single-port robot-assisted radical cystectomy with exploratory comparison to a contemporaneous da Vinci Xi single-port cohort. Minerva Urol Nephrol Zhu Q, Wang J, Wei Y, Liu W, Shen L, Fankhauser CD, Gu M. PMID: 42438984 [PubMed - indexed for MEDLINE]
	Off-clamp and on-clamp robotic-assisted partial nephrectomy in ischemia-sensitive patients: a multicenter propensity score-matched study (RAPN OFF-CLAMP study - UroCCR 187). Minerva Urol Nephrol Schurdi-Levraud L, Margue G, Geshkovska A, Bensalah K, Ricolleau C, Bruyere F, Champy C, Michel C, Surlemont L, Fantoni JC, Fontenil A, Sarrazin C, Beauval JB, Parier B, Panthier F, Patard JJ, Belas O, Bigot P, Bernhard JC. PMID: 42438983 [PubMed - indexed for MEDLINE]
	First report of safety and outcomes of radiofrequency ablation of renal tumors using a new automated energy delivery-controlled system. Minerva Urol Nephrol Ferrillo G, Baldassarre E, Sirugo T, Romano S, Lanza E, Poretti D, Saita A, Levi R, Lughezzani G, Buffi NM, Casale P, Francone M, Pedicini V. PMID: 42438982 [PubMed - indexed for MEDLINE]
	Perioperative safety and short-term survival outcomes of radical nephrectomy with thrombectomy in geriatric renal cell carcinoma patients with venous tumor thrombus. Minerva Urol Nephrol Guan Y, Hong P, Xiao R, Tang S, Liu Z, Tian X, Wang G, Ma L, Zhang H, Zhang S. PMID: 42438981 [PubMed - indexed for MEDLINE]
	YAU-RCC spotlight: where evidence ends and consensus begins for renal cell carcinoma. Insights from the Advanced Urologic Cancer Consensus Conference (AUC3) 2025. Minerva Urol Nephrol Mollica V, Yekedüz E, Amparore D, Campi R, European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group. PMID: 42438977 [PubMed - in process]
	Tumor necrosis factor inhibitor prescribing and persistence by specialty in radiographic axial spondyloarthritis: a Korean claims study. Korean J Intern Med Koo BS, Kim YJ, Lee YJ, Kim YG, Kim TH. PMID: 42438916 [PubMed - indexed for MEDLINE]
	Prognostic analysis according to adjuvant chemotherapy and anti-HER2 therapy following surgery in T1a/b HER2-positive breast cancer. Korean J Intern Med Park W, Suh KJ, Seo J, Kim SH, Kim YJ, Shin HC, Kim EK, Kim IA, Park SY, Kim JH. PMID: 42438913 [PubMed - indexed for MEDLINE]
	Restrictive lung function and smoking increase lung cancer risk in tuberculosis survivors: a cohort study. Korean J Intern Med Lee YG, Gil HI, Seo D, Kim BG, Lee H, Kim YH, Nam H, Ham SY, Kang DY, Song JU. PMID: 42438911 [PubMed - indexed for MEDLINE]
	The medical impact of emergent banning of N-nitrosodimethylamine: contaminated antihypertensive drug. Korean J Intern Med Ahn J, Won S, Park JH, Lee HY. PMID: 42438908 [PubMed - indexed for MEDLINE]
	Hepatitis B core-related antigen as a multifaceted biomarker in chronic hepatitis B: implications for immune activity and hepatocellular carcinoma prediction. Korean J Intern Med Tak KY, Kim SH, Song MJ. PMID: 42438905 [PubMed - indexed for MEDLINE]
	Incidence and Spectrum of Adverse Events With Enfortumab Vedotin Therapy in Advanced or Metastatic Urothelial Carcinoma: Evidence From a Systematic Review and Meta-Analysis. Arch Esp Urol Li X, Leng W, Hu W, Gao D, Zhu Z, Lin J, Xu C. PMID: 42438880 [PubMed - indexed for MEDLINE]
	Age as a Predictor of Prostate Cancer Risk Stratification in Systematic Prostate Biopsy. Arch Esp Urol Bostanci C, Erdem K. PMID: 42438876 [PubMed - indexed for MEDLINE]
	Survival in Synchronous Versus Metachronous Bladder and Prostate Cancer. Arch Esp Urol Yalç, Tuncay E, Arslan S, Araci HE, Köseo. PMID: 42438875 [PubMed - indexed for MEDLINE]
	Radiologic and Lipid Metabolism Imaging Features Associated with FABP2 Expression in Clear Cell Renal Cell Carcinoma: An Interpretable Supervised Machine Learning Radiogenomic Study. Arch Esp Urol Greco F, Cataldo M, Panunzio A, Tafuri A, Beomonte Zobel B, Mallio CA. PMID: 42438874 [PubMed - indexed for MEDLINE]
	Immunohistochemistry-Based Molecular Subtyping in Muscle-Invasive Bladder Cancer: Predicting Response to Neoadjuvant Chemotherapy. Arch Esp Urol Pérez-Bartivas L, Leiva-Cepas F, Ponferrada D, Flores-Paco P, Atance-Morales V, Martínez M, Armenta-Triviño A, Rodríguez-Alonso RM, De La Haba-Rodríguez J, Aranda E, Méndez-Vidal MJ. PMID: 42438872 [PubMed - indexed for MEDLINE]
	Magnetic Resonance Imaging as a Predictor of Early Discontinuation of Active Surveillance in Patients with Prostate Cancer. Arch Esp Urol Domínguez Argomedo R, de Pablos-Rodríguez P, Pelechano Gómez P, Martín García MI, Arrizabalaga Solano A, Rodríguez Part V, Beamud Cortés M, Calatrava Fons A, Gutiérrez Castañé C, Gómez-Ferrer Lozano Á, García Cortés Á, López Gonzalez JA, Domínguez Escrig JL, Romero Hinostroza C, Sánchez Aparisi E, Casanova Ramón-Borja J. PMID: 42438871 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 1954554

Seite 1 von 97728

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung